Public Company News

X Financial to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 20, 2025

SHENZHEN, China, March 18, 2025 /PRNewswire/ -- X Financial (NYSE: XYF) (the "Company"), a leading online personal finance company inChina, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2024, before the open of U.S. m...

2025-03-18 18:00 2755

So-Young Reschedules Release of Fourth Quarter and Full Year 2024 Financial Results to March 28, 2025

BEIJING, March 18, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has rescheduled the ...

2025-03-18 17:00 2766

Tencent Music Entertainment Group Announces Fourth Quarter and Full-Year 2024 Unaudited Financial Results

SHENZHEN, China, March 18, 2025 /PRNewswire/ --Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform inChina, today announced its unaudited financial results for the fourth quarter and full year endedDecem...

2025-03-18 17:00 3401

HUYA Inc. Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and Announces Dividend Plan

GUANGZHOU, China, March 18, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform inChina, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2024. Fourth Quarter 2024 Highlights[1] *...

2025-03-18 16:10 2564

Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension

This partnership aims to enhance ophthalmic care by providing better treatment for post-operative inflammation and pain in patients across 11 countries. TAIPEI, March 18, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (6838.TW) today announced an exclusive licensing agreement with Cipl...

2025-03-18 16:00 2377

FinVolution Group Announces New Share Repurchase Program Up To US$150 million

SHANGHAI, March 17, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform inChina, Indonesia and the Philippines, today announced that the board of directors of the Company (the "Board") has authorized a new share repurchase program (the...

2025-03-18 06:02 2728

TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025

TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening TaiMed Biologics will reshape HIV treatment management and seeks strategic collaborations with global pharmaceutical partners for the commercialization of its long-acting HIV maintenance thera...

2025-03-18 06:00 1947

FinVolution Group Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

-Full Year 2024 Transaction Volume reached RMB206.2 billion, up 6.1% year-over-year- -Full Year 2024 International Transaction Volume exceeded RMB10.1 billion, up 27.8% year-over-year- -Full Year International Revenues reached RMB2.5 billion, up 18.5% year-over-year and representing 19.4% of to...

2025-03-18 06:00 2777

Health in Tech Expands Executive Team to Drive Growth and Innovation

* Dustin Plantholt appointed Chief Growth Officer * Chris Kurtenbach appointed Chief Operating Officer * (Jonathan) Del Lockett appointed Chief Strategy Officer * Jenni Guerrica appointed Chief Information Security Officer STUART, Fla., March 17, 2025 /PRNewswire/ -- Health In Tech (Nasdaq:...

2025-03-18 04:30 2787

Health In Tech Announces Fourth Quarter and Full Year 2024 Financial Results

* Total audited revenue for 2024 was $19.5 million. * The first two months of 2025, our unaudited revenue is about $5.7million, more than 50% growth year over year for the first two months of 2024, and exceeded the revenue of the entire Q1 of 2024 * Cash and cash equivalents were $7.8 millio...

2025-03-18 04:30 2764

MicroCloud Hologram Inc. Researches CV-QNN (Continuous Variable Quantum Neural Networks) Technology and Builds Variational Quantum Circuits Embedded in CV Architecture

SHENZHEN, China, March 17, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, they are researching CV-QNN (Continuous Variable Quantum Neural Networks) technology, with the aim of building Variational Quantum Circuits embedded i...

2025-03-17 22:00 2443

NEXTBIOMEDICAL, Fast Resorbable Microsphere 'Nexsphere-F' : Clinical Study Results on 155 Patients Published in the JVIR

* Safety and Excellent Pain Relief Effect after Musculoskeletal Pain Embolization SEOUL, South Korea, March 17, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LDT, announced that clinical study results of Nexsphere-F™, a resorbable embolic agent for treating joint pain, have been published in the est...

2025-03-17 21:00 2158

MicroAlgo Inc. Develops Multi-Simulator Collaborative Algorithm Based on Subgraph Isomorphism to Enhance Quantum Computer Performance Using Distributed Computing Advantages

SHENZHEN, China, March 17, 2025 /PRNewswire/ -- MicroAlgo Inc. (NASDAQ: MLGO), (the "Company"or "MicroAlgo"), today announced the introduction of an innovative solution: a multi-simulator collaborative algorithm based on subgraph isomorphism, aimed at overcoming the limitations of qubit numbers a...

2025-03-17 21:00 2911

NIP Group Joins the Esports World Cup Foundation Club Partner Program Ahead of the 2025 Esports World Cup

STOCKHOLM, March 17, 2025 /PRNewswire/ -- NIP Group (NASDAQ: NIPG) has officially been included in the Esports World Cup Foundation (EWCF) Club Partner Program ahead of the tournament opening ceremony in July. As a returning member, this renewed partnership with the EWCF will provide substantial...

2025-03-17 21:00 2826

WuXi AppTec Revenue and Profit Achieved Steady QoQ Growth in 2024, Meeting Full-year Guidance; Q4 Revenue and Profit Both Reached Record Highs

* Fourth-Quarter Revenue Reached RMB11,539 Million, Up 6.9% Year-over-Year * 2024 Revenue Reached RMB39,241 Million, Up 5.2% Year-over-Year (Excluding COVID-19 Commercial Project of 2023) * Full-Year Net Profit Attributable to the Owners of the Company Reached RMB9,450 Million[1], Diluted Ea...

2025-03-17 20:19 3165

NaaS Technology Inc. and Xiaomi Auto Join Forces to Enhance Smart EV Charging Ecosystem

BEIJING, March 17, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced a strategic partnership with Xiaomi Auto, a subsidiary of Xiaomi Group (HKEX: 1810). Through this collaboration, two co...

2025-03-17 18:00 2404

CBAK Energy Reports Full Year of 2024 Unaudited Financial Results

DALIAN, China, March 17, 2025 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company") a leading lithium-ion battery manufacturer and electric energy solution provider inChina, today reported its unaudited financial results for the full year of 2024 endedDecem...

2025-03-17 16:00 2903

Fangzhou Inc.'s H2H Smart Healthcare Platform Honored as one of Guangdong's Premier High-Tech Innovation Products

GUANGZHOU, China, March 17, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, today announced that its proprietary "H2H Smart Healthcare Innovation Platform" has been distinguished as a "2024Guangdong Province Premier High-Qual...

2025-03-17 15:43 1850

Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

HONG KONG, March 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for the first-line treatment of recurrent or metastatic nasop...

2025-03-17 11:49 2021

Baidu Unveils ERNIE 4.5 and Reasoning Model ERNIE X1, Makes ERNIE Bot Free Ahead of Schedule

* With the launch of ERNIE 4.5 and ERNIE X1, ERNIE Bot is made free to the public ahead of schedule, and users can access both models free of charge. * As a deep-thinking reasoning model with multimodal capabilities, ERNIE X1 delivers performance on par with DeepSeek R1 at only half the price....

2025-03-16 16:36 3257
1 ... 118119120121122123124 ... 779

Week's Top Stories